All the latest news on the marijuana space delivered directly to your inbox.
Read our Investor Dashboard on OTC:ABCCF TSX.v ABCN
There will be a sudden wave of "Marijuana Millionaires" in 2017 - will you be one?

13x13x1 READ MORE
How To Invest in the Emerging Marijuana Market.
Tweed and DNA Genetics renew and expand their partnership

Tweed Inc., wholly-owned subsidiary of Canopy Growth Corporation and DNA Holding LLC are proud to announce the renewal and expansion of their partnership through to October 2022. Together they are committed to bringing the best possible cannabis to Canada.

13x13x1 READ MORE
MYM Announces Closing of First Tranche of Non-Brokered Financing

MYM Nutraceuticals Inc., (CSE: MYM) announces it has closed the first tranche of its non-brokered private placement of 5,709,000 units at a price of $0.50 per unit for gross proceeds of $2,854,500.

13x13x1 READ MORE
Global Payout, Inc. is Finalizing Audit in Preparation for its Listing on the OTCQB Venture Marketplace.

Global Payout, Inc. (OTCPink: GOHE) announces it is in the final stages of performing a 2-year audit to become a fully reporting SEC company. Upon completion of the audit, GOHE will immediately apply to be listed on the OTCQB Venture Marketplace..

13x13x1 READ MORE
Please see full disclaimers on the website applicable to all content provided by TSI, wherever published or re-published:

This news release/advertorial is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in small-cap and micro-cap securities is highly speculative and carries an extremely high degree of risk. This website makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Compensation: A thirty-six-thousand-dollar investor relations budget is being managed by The Seed Investor. Any funds leftover after expenses for research, overhead, advertising and public relations related to InMed Pharmaceuticals Inc. (ticker symbol (CSE: IN; OTCQB: IMLFF) will be considered profit. The Seed Investor and/or entities related to The Seed Investor hold shares in (CSE: IN; OTCQB: IMLFF) and intend to sell those shares. Please review all investment decisions with a licensed inv­estment advisor. 

32x32x1   32x32x2
9375 E Shea Blvd Ste 100
Scottsdale 85260
©2019, All Rights Reserved  |  Unsubscribe   |   View this in Browser

To keep receiving emails from us, please add us to your address book.